| Stephanie Lauren Donchin, CRNA | |
|
5255 Loughboro Rd Nw, Washington, DC 20016-2633 | |
| (202) 537-4000 | |
| Not Available |
| Full Name | Stephanie Lauren Donchin |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 5255 Loughboro Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538646773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN1058242 (District Of Columbia) | Primary |
| 163W00000X | Registered Nurse | RN2321981 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Surgical Anesthesia Associates Pllc | 5890739205 | 101 |
News Archive
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
Pfizer Inc. announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma, or liver cancer. Following a review by the independent Data Monitoring Committee, the study was discontinued based on a higher incidence of serious adverse events in the sunitinib arm compared to the sorafenib arm and the fact that sunitinib did not meet the criteria to demonstrate that it was either superior or non-inferior to sorafenib in the survival of patients with advanced hepatocellular cancer.
Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
Kaiser Health News staff writer Jessica Marcy reports: "Under federal rules, most people with disabilities who are younger than 65 aren't eligible for Medicare until more than two years after they qualify for Social Security disability income.
› Verified 9 days ago
| Entity Name | Surgical Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811930647 PECOS PAC ID: 5890739205 Enrollment ID: O20050616000610 |
News Archive
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
Pfizer Inc. announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma, or liver cancer. Following a review by the independent Data Monitoring Committee, the study was discontinued based on a higher incidence of serious adverse events in the sunitinib arm compared to the sorafenib arm and the fact that sunitinib did not meet the criteria to demonstrate that it was either superior or non-inferior to sorafenib in the survival of patients with advanced hepatocellular cancer.
Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
Kaiser Health News staff writer Jessica Marcy reports: "Under federal rules, most people with disabilities who are younger than 65 aren't eligible for Medicare until more than two years after they qualify for Social Security disability income.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Lauren Donchin, CRNA 11921 Travistock Ct, Reston, VA 20191-2729 Ph: (217) 341-0743 | Stephanie Lauren Donchin, CRNA 5255 Loughboro Rd Nw, Washington, DC 20016-2633 Ph: (202) 537-4000 |
News Archive
In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofovir (FTC/TDF), experienced an average of 43.8% fewer HIV infections than those who received a placebo pill. New England Journal of Medicine, is the first evidence that this new HIV prevention method, called pre-exposure prophylaxis or PrEP, reduces HIV infection risk in people.
Pfizer Inc. announced today the discontinuation of the SUN 1170 Phase 3 open-label study of Sutent(r) (sunitinib malate) in advanced hepatocellular carcinoma, or liver cancer. Following a review by the independent Data Monitoring Committee, the study was discontinued based on a higher incidence of serious adverse events in the sunitinib arm compared to the sorafenib arm and the fact that sunitinib did not meet the criteria to demonstrate that it was either superior or non-inferior to sorafenib in the survival of patients with advanced hepatocellular cancer.
Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.
Shared Health, Inc., Tennessee's largest public/private health information exchange (HIE) has partnered with MEDai, an Elsevier company, to provide a rich, interoperable, clinically relevant HIE platform to the state of Tennessee. This partnership delivers best in class solutions and technologies that support clinical excellence and operating efficiencies.
Kaiser Health News staff writer Jessica Marcy reports: "Under federal rules, most people with disabilities who are younger than 65 aren't eligible for Medicare until more than two years after they qualify for Social Security disability income.
› Verified 9 days ago
Miss Ore-oluwa Odulana Lima Da Silva, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7504 | |
Kathryn T Turner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-946-5100 Fax: 301-929-0348 | |
Glenise Lynn Sanchez Perez, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Barbara Pursell, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-4904 | |
Vera Tantoco, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 | |
Donna Jasinski, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 | |
Ms. Jane Ann Skelton, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 110 Irving St Nw, Dept. Anesthesia Angie Edwards, Washington, DC 20016 Phone: 202-877-7000 |